Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 23% ± 5% | |
transit amplifying cell | 3 studies | 33% ± 7% | |
natural killer cell | 3 studies | 21% ± 7% |
Insufficient scRNA-seq data for expression of CHEK1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 344.69 | 1441 / 1445 | 100% | 16.57 | 183 / 183 |
uterus | 100% | 218.83 | 170 / 170 | 99% | 22.05 | 454 / 459 |
stomach | 100% | 250.73 | 359 / 359 | 98% | 17.18 | 281 / 286 |
intestine | 100% | 402.86 | 966 / 966 | 98% | 17.98 | 517 / 527 |
ovary | 100% | 327.91 | 180 / 180 | 98% | 13.42 | 421 / 430 |
bladder | 100% | 247.33 | 21 / 21 | 96% | 16.58 | 485 / 504 |
breast | 100% | 247.62 | 459 / 459 | 94% | 12.36 | 1056 / 1118 |
skin | 100% | 851.93 | 1807 / 1809 | 93% | 11.86 | 441 / 472 |
lung | 97% | 229.50 | 561 / 578 | 93% | 14.41 | 1071 / 1155 |
pancreas | 98% | 214.51 | 323 / 328 | 83% | 6.88 | 148 / 178 |
kidney | 100% | 302.90 | 89 / 89 | 70% | 4.38 | 627 / 901 |
brain | 99% | 188.41 | 2606 / 2642 | 68% | 7.30 | 479 / 705 |
thymus | 100% | 214.47 | 650 / 653 | 58% | 4.56 | 352 / 605 |
prostate | 100% | 318.51 | 245 / 245 | 50% | 2.44 | 253 / 502 |
liver | 89% | 124.43 | 201 / 226 | 50% | 4.07 | 202 / 406 |
adrenal gland | 100% | 245.81 | 258 / 258 | 34% | 2.75 | 79 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.27 | 29 / 29 |
spleen | 100% | 359.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.03 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.83 | 1 / 1 |
adipose | 100% | 250.95 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 328.67 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 83% | 104.01 | 713 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 69% | 771.53 | 637 / 929 | 0% | 0 | 0 / 0 |
muscle | 55% | 53.09 | 440 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 1.18 | 22 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010569 | Biological process | regulation of double-strand break repair via homologous recombination |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0006281 | Biological process | DNA repair |
GO_0045839 | Biological process | negative regulation of mitotic nuclear division |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0001833 | Biological process | inner cell mass cell proliferation |
GO_0006974 | Biological process | DNA damage response |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0090399 | Biological process | replicative senescence |
GO_0070317 | Biological process | negative regulation of G0 to G1 transition |
GO_0006260 | Biological process | DNA replication |
GO_0006338 | Biological process | chromatin remodeling |
GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
GO_0006997 | Biological process | nucleus organization |
GO_0044818 | Biological process | mitotic G2/M transition checkpoint |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0046602 | Biological process | regulation of mitotic centrosome separation |
GO_1902742 | Biological process | apoptotic process involved in development |
GO_0006915 | Biological process | apoptotic process |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0071313 | Biological process | cellular response to caffeine |
GO_0006468 | Biological process | protein phosphorylation |
GO_2000279 | Biological process | negative regulation of DNA biosynthetic process |
GO_0042770 | Biological process | signal transduction in response to DNA damage |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0045787 | Biological process | positive regulation of cell cycle |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0005615 | Cellular component | extracellular space |
GO_0005813 | Cellular component | centrosome |
GO_0005657 | Cellular component | replication fork |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000794 | Cellular component | condensed nuclear chromosome |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0035402 | Molecular function | histone H3T11 kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CHEK1 |
Protein name | Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Checkpoint kinase-1) Checkpoint kinase 1 non-specific serine/threonine protein kinase (EC 2.7.11.1) CHEK1 |
Synonyms | CHK1 |
Description | FUNCTION: Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA . May also negatively regulate cell cycle progression during unperturbed cell cycles . This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome . Recognizes the substrate consensus sequence [R-X-X-S/T] . Binds to and phosphorylates CDC25A, CDC25B and CDC25C . Phosphorylation of CDC25A at 'Ser-178' and 'Thr-507' and phosphorylation of CDC25C at 'Ser-216' creates binding sites for 14-3-3 proteins which inhibit CDC25A and CDC25C . Phosphorylation of CDC25A at 'Ser-76', 'Ser-124', 'Ser-178', 'Ser-279' and 'Ser-293' promotes proteolysis of CDC25A . Phosphorylation of CDC25A at 'Ser-76' primes the protein for subsequent phosphorylation at 'Ser-79', 'Ser-82' and 'Ser-88' by NEK11, which is required for polyubiquitination and degradation of CDCD25A . Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression . Also phosphorylates NEK6 . Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination . Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation . Also promotes repair of DNA cross-links through phosphorylation of FANCE . Binds to and phosphorylates TLK1 at 'Ser-743', which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A . This may enhance chromatin assembly both in the presence or absence of DNA damage . May also play a role in replication fork maintenance through regulation of PCNA . May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones (By similarity). Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes (By similarity). May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest . Phosphorylates SPRTN, promoting SPRTN recruitment to chromatin . Reduces replication stress and activates the G2/M checkpoint, by phosphorylating and inactivating PABIR1/FAM122A and promoting the serine/threonine-protein phosphatase 2A-mediated dephosphorylation and stabilization of WEE1 levels and activity . .; FUNCTION: [Isoform 2]: Endogenous repressor of isoform 1, interacts with, and antagonizes CHK1 to promote the S to G2/M phase transition. . |
Accessions | E7EPP6 ENST00000711049.1 ENST00000525396.5 ENST00000534070.5 [O14757-1] ENST00000532449.6 [O14757-1] E9PPA5 ENST00000527013.6 E9PKQ3 ENST00000428830.6 [O14757-1] ENST00000526937.5 ENST00000532669.5 E9PQW7 E9PJI4 ENST00000427383.6 ENST00000534685.5 Q6W8P8 E9PRU7 ENST00000544373.5 [O14757-2] A0A087WT52 ENST00000438015.7 [O14757-1] ENST00000278916.8 [O14757-3] ENST00000524737.6 [O14757-1] ENST00000531607.5 O14757 |